Tirzepatide
A Study to Investigate Weight Management With Bimagrumab (LY3985863) and Tirzepatide (LY3298176), Alone or in Combination, in Adults With Obesity or Overweight
Eli Lilly · Phase 2 · Active, not recruiting · Enrollment 252
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.